Latest Blood Cancer Research Updates – Voice of Biotecnika
Voice of Biotecnika – Episode No: 40
Today’s podcast is all about Believing Miracles Can Happen. We are going to talk about Cancer today, with a special focus on Blood cancer.
Blood Cancer is the abnormal or uncontrolled growth of blood cells. The most commonly diagnosed blood cancers are non-Hodgkin lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and multiple myeloma.
Non-Hodgkin Lymphoma occurs when large B-cell lymphoma, grows rapidly, and follicular lymphoma grows slowly. Chronic lymphocytic leukemia (CLL) occurs due to uncontrolled growth of B lymphocytes, which is a type of white blood cell. Acute myeloid leukemia (AML) is fast-growing cancer, common in adults in which the bone marrow produces abnormal amounts of white blood cells, red blood cells, and platelets. Acute lymphoblastic leukemia (ALL) is a fast-growing type of leukemia in which the bone marrow makes too many immature lymphocytes. Multiple myelomas occur when the body makes too many plasma cells, which develop from B lymphocytes in the bone marrow.
Cancer is a life-threatening disease, is considered a taboo in many cultures. But now its time, not to be depressed as new research offers a ray of hope for treatment as researchers are contributing immensely towards controlling the untamed growth of bold cancer cells.
Acute myeloid leukemia (AML) is one of the most common and lethal acute leukemias. According to the American Cancer Society every year 19,520 cases are diagnosed and about 10,670 people die annually from it, due to the increase of malignant myeloid progenitor cells. It’s a deadly disease as after initial diagnosis only twenty-five percent of patients survive beyond five years.
Why there is no permanent cure for it because the detailed mechanisms for the occurrence and progression of acute myeloid leukemia are incompletely understood. Presently, the treatment strategies for patients with this disease include chemotherapy, targeted therapy, and hematopoietic stem cell transplantation. Though the significant development in treatment strategies has enhanced the therapeutic outcomes of patients with acute myeloid leukemia over the last few decades. But nonetheless, a large number of patients face relapsing of the disease and hence die of the disease. Therefore there is an utmost need to understand the molecular processes and mechanisms which are responsible for acute myeloid leukemia development and progression of the disease. The mechanisms are of great importance as it helps to develop reliable therapeutic approaches for patients with this disease.